Ceftaroline desensitization procedure in a pregnant patient with multiple drug allergies

Open Forum Infectious Diseases

Volumn 2, Issue 1, 2015, Pages

  Kuhlen, James L ^a,b   Blumenthal, Kimberly G ^a,b   Sokol, Caroline L ^a,b   Balekian, Diana S ^a,b   Weil, Ana A ^a,b   Varughese, Christy A ^a   Shenoy, Erica S ^a,b   Banerji, Aleena ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Ceftaroline; Cross reactivity; Desensitization procedure; Drug allergy; lactam

Indexed keywords

AMOXICILLIN; CEFCLIDIN; CEFEPIME; CEFTAROLINE; CEFTOBIPROLE MEDOCARIL; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ALLERGIC URTICARIA; ARTICLE; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; CYSTIC FIBROSIS; DESENSITIZATION; DRUG CROSS REACTIVITY; DRUG HYPERSENSITIVITY; DYSPNEA; EOSINOPHILIA; FEMALE; GRAM STAINING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG AUSCULTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEUTROPENIA; NOSE OBSTRUCTION; PREGNANT WOMAN; PRIORITY JOURNAL; PRURITUS; RASH; SKIN TEST; SORE THROAT; VOMITING;

EID: 84978328028     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv027     Document Type: Article

References (23)

1. Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol 2011; 71:684-700.
2. Kelly WN. Potential risks and prevention, part 1: fatal adverse drug events. Am J Health Syst Pharm 2001; 58:1317-24.
3. Lee CW, Matulonis UA, Castells MC. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol 2004; 95:370-6.
4. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001; 345:804-9.
5. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259-73.
6. Blumenthal KG, Saff RR, Banerji A. Evaluation and management of a patient with multiple drug allergies. Allergy Asthma Proc 2014; 35:197-203.
7. Iammatteo M, Blumenthal KG, Saff R, et al. Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review. J Allergy Clin Immunol Pract 2014; 2:768-74.
8. Hesterberg PE, Banerji A, Oren E, et al. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. J Allergy Clin Immunol 2009; 123:1262-7.e1.
9. Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008; 122:574-80.
10. File TM, Wilcox MH, Stein GE. Summary of ceftaroline fosamil clinical trial studies and clinical safety. Clin Infect Dis 2012; 55(Suppl 3): S173-80.
11. Pasquale TR, Tan MJ, Trienski TL, File TM Jr. Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients. J Chemother 2015: 27:29-34.
12. Laboratories F. TEFLARO® (ceftaroline fosamil) injection for intravenous (IV) use. 2010:22.
13. Stryjewski ME, Jones RN, Corey GR. Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA. Diagn Microbiol Infect Dis 2014; 81:183-8.
14. Casapao AM, Davis SL, Barr VO, et al. Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy. Antimicrob Agents Chemother 2014; 58:2541-6.
15. Jones JM, Richter LM, Alonto A, Leedahl DD. Desensitization to ceftaroline in a patient with multiple medication hypersensitivity reactions. Am J Health Syst Pharm 2015; 72:198-202.
16. Daulat S, Solensky R, Earl HS, et al. Safety of cephalosporin administration to patients with histories of penicillin allergy. J Allergy Clin Immunol 2004; 113:1220-2.
17. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005; 115: 1048-57.
18. Pichichero ME, Zagursky R. Penicillin and cephalosporin allergy. Ann Allergy Asthma Immunol 2014;112:404-12.
19. Reyes MP, Ostrea EM, Cabinian AE, et al. Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant? Am J Obstet Gynecol 1989; 161:977-81.
20. Bourget P, Fernandez H, Delouis C, Ribou F. Transplacental passage of vancomycin during the second trimester of pregnancy. Obstet Gynecol 1991; 78(5 Pt 2):908-11.
21. MacCulloch D. Vancomycin in pregnancy. N Z Med J 1981; 93:93-4.
22. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59(RR-10):1-36.
23. ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol 2011; 117: 1019-27.